Readystate Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$621K Buy
+22,100
New +$588K 0.03% 561
2025
Q2
Sell
-209,200
Closed -$5.3M 865
2025
Q1
$5.3M Buy
209,200
+121,500
+139% +$3.18M 0.18% 92
2024
Q4
$2.33M Sell
87,700
-331,500
-79% -$8.99M 0.07% 277
2024
Q3
$12.1M Buy
419,200
+398,800
+1,955% +$11.6M 0.23% 187
2024
Q2
$571K Sell
20,400
-4,400,000
-100% -$121M 0.02% 481
2024
Q1
$123M Buy
4,420,400
+504,100
+13% +$14M 1.73% 4
2023
Q4
$113M Buy
+3,916,300
New +$118M 3.83% 1
2023
Q2
Sell
-7,600
Closed -$310K 387
2023
Q1
$310K Buy
+7,600
New +$328K 0.03% 243

Other funds holding PFE

Readystate Asset Management's PFE Position: Q1 2025 in Review

Readystate Asset Management sold out of Pfizer (PFE) in Q1 2025, closing a stake of 39,346 shares — an estimated $1.03M sold.

Readystate Asset Management first reported a position in PFE in Q4 2024 and held it in 1 quarter. The position peaked at $1.04M in Q4 2024. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Readystate Asset Management reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Readystate Asset Management sold 39,346 Pfizer shares in Q1 2025, an estimated $1.03M.
  • Readystate Asset Management first reported a position in Pfizer in Q4 2024 and held it in 1 quarter.
  • Readystate Asset Management's Pfizer position peaked at $1.04M in Q4 2024.
  • 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Readystate Asset Management's 13F filing for Q1 2025, filed 6 May 2025.